Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Core Viewpoint - Dyadic International is positioned at a commercial inflection point with multiple products entering the market and active revenue streams, focusing on scalable, animal-free recombinant protein solutions for various sectors [2]. Company Overview - Dyadic International was founded in 1979 and has a history of innovation in industrial biomanufacturing, particularly in the industrial enzymes business, which was acquired by DuPont for $75 million in 2015 [4]. - The company has transitioned its focus towards producing high-value input proteins in sustainable and predictable areas, moving away from traditional animal-derived proteins [4][5].